Rep. Chip Roy calls for House to impeach VP Kamala Harris

New Post Public Reply Private Reply Replies (0) Message Board
energy_wave
436
Rep. Chip Roy calls for House to impeach VP Kamala Harris for ‘lying’ about Biden’s mental capacity



Quote:
Rep. Chip Roy wants the House to impeach Vice President Kamala Harris, arguing she has breached her oath of office by “lying” to the public about President Biden’s apparent mental decline and failing to use her constitutional power under the 25th Amendment to remove him from office.

The Texas Republican also wants his House colleagues to conduct oversight hearings to find out who else in Mr. Biden’s orbit knew about his condition before last week’s disastrous debate performance against a coherent Donald Trump.

“Kamala Harris should be impeached for lying to America about the state of President Biden’s mental capacity to carry out the powers and duties of the office — and shirking her unique constitutional obligation to take the necessary steps to invoke the 25th Amendment,” Mr. Roy posted Wednesday on X.

He added that House Republicans should hold hearings when they return to Washington next week to expose what appears to be a cover-up by the Biden administration.

“What did they know, and when did they know it?” Mr. Roy said. “And who is ‘they?’”

On Friday, the day after the debate, Mr. Roy said he would introduce a resolution calling on Ms. Harris to invoke the 25th Amendment and convene the Biden Cabinet to declare the president unable to discharge the duties and powers of the office. He filed the resolution later that day.

Some Democrats, including Texas Rep. Lloyd Doggett, have begun public calls for Mr. Biden to abandon his presidential campaign and let someone else in the party replace him as the nominee. But there is not a similar campaign in the party to pressure Mr. Biden to step down immediately or for the Cabinet to invoke the 25th Amendment.

Republicans, however, are seizing on the moment to argue that Mr. Biden is unfit to serve as president now and in the future.

“Democrat Party elites and their media mouthpieces are now obsessed with replacing Biden on the ballot. But if he’s unfit to run for president, he certainly isn’t fit to *be* president,” said Sen. J.D. Vance, Ohio Republican and a contender to be Mr. Trump’s running mate.

“If he doesn’t run again, he needs to resign as commander in chief,” Mr. Vance posted on X, referring to Mr. Biden.

Donald Trump Jr. posted in agreement with Mr. Vance.

“The real ’Big Lie’ — pushed by every major Democrat and the entire left-wing media for 4 years now — is that Joe Biden was ever mentally fit to serve as commander in chief,” he said.

Mr. Roy piled on, arguing that Democrats who claim they didn’t know about Mr. Biden’s mental state are just spewing “BS.”

Mr. Biden “knew — and it’s impeachable that he lied & covered up his dementia,” Mr. Roy said.

He claimed Mr. Biden’s advisers, first lady Jill Biden, top Democrats like Ms. Harris, former House Speaker Nancy Pelosi, Senate Majority Leader Charles E. Schumer and House Democratic Leader Hakeem Jeffries all knew — “The whole time.”


https://www.washingtontimes.com/news/2024/jul...a-harris-/
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading